ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -33 مورد

Bismuth subcitrate: International drug information (concise)

Bismuth subcitrate: International drug information (concise)
2025© UpToDate, Inc. and its affiliates and/or licensors. All Rights Reserved.
For abbreviations, symbols, and age group definitions show table
Index Terms
  • Bismuth Potassium Citrate;
  • Bismuth Tripotassium Dicitrate;
  • Colloidal Bismuth Subcitrate;
  • Tri-potassium Di-citrato Bismuthate;
  • Tripotassium Bismuth Dicitrate;
  • Tripotassium Dicitratobismuthate
Pharmacologic Category
  • Gastrointestinal Agent, Miscellaneous
Reported Use

Eradication of Helicobacter pylori (as part of appropriate combination therapy) in patients with gastric and duodenal ulcers.

Dosage Range

Note: Doses below are expressed as bismuth subcitrate. Tablet strengths may be represented as bismuth subcitrate or as bismuth oxide equivalent; bismuth subcitrate 300 mg is equivalent to bismuth oxide 120 mg.

Adults: Oral: 300 mg 4 times daily as part of an appropriate combination regimen.

Product Availability

Product available in various countries; not currently available in the United States.

Dosage Forms

Tablet, Oral: 300 mg [equivalent to bismuth (III) oxide 120 mg]

Topic 148132 Version 2.0